ACOD1 and neoplasm: Importantly, OVA&si-Irg1-LNP demonstrated potent anti-tumor efficacy when used alone or in combination with an anti-PD-1 antibody and also increased the infiltration of immune cells, including DCs, macrophages, and T cells.